Author:
Sato Toyotaka,Uemura Kojiro,Yasuda Mitsuru,Maeda Aiko,Minamoto Toshifumi,Harada Kazuki,Sugiyama Michiyo,Ikushima Shiori,Yokota Shin-ichi,Horiuchi Motohiro,Takahashi Satoshi,Asai Testuo
Funder
Takeda Science Foundation
Japan Society for the Promotion of Science
Japan Science and Technology Agency
Government of Japan Ministry of Health Labour and Welfare
Japan Agency for Medical Research and Development
Reference20 articles.
1. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009;Johnson;Emerg. Infect. Dis.,2012
2. Pathogenic lineage of mcr-negative colistin-resistant Escherichia coli, Japan, 2008-2015;Sato;Emerg. Infect. Dis.,2016
3. Tigecycline nonsusceptibility occurs exclusively in fluoroquinolone-resistant Escherichia coli clinical isolates, including the major multidrug-resistant lineages O25b:H4-ST131-H30R and O1-ST648;Sato;Antimicrob. Agents Chemother.,2017
4. Isolation of human lineage,fluoroquinolone-resistant and extended-β-lactamase-producing Escherichia coli isolates from companion animals in Japan;Sato;Antibiotics (Basel).,2021
5. Companion animals are spillover hosts of the multidrug-resistant human extraintestinal Escherichia coli pandemic clones ST131 and ST1193;Kidsley;Front. Microbiol.,2020